Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousStem CellsTransplantation ConditioningPeripheral Blood Stem Cell TransplantationMultiple MyelomaMelphalanBone Marrow TransplantationCombined Modality TherapyHematopoietic Stem Cell MobilizationTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsRemission InductionSalvage TherapyGraft vs Host DiseaseAntigens, CD34Disease-Free SurvivalLymphoma, Non-HodgkinRecurrenceMyeloablative AgonistsHodgkin DiseaseEtoposideCyclophosphamideHematologic NeoplasmsCarmustineGraft SurvivalLiver TransplantationWhole-Body IrradiationBone Marrow PurgingCytarabineSurvival RateHematopoiesisRetrospective StudiesBusulfanVincristineSurvival AnalysisCell DifferentiationThiotepaGranulocyte Colony-Stimulating FactorEmbryonic Stem CellsLeukapheresisMesenchymal Stem Cell TransplantationCell TransplantationBone Marrow CellsTransplantation ChimeraAdult Stem CellsKidney TransplantationTime FactorsDexamethasoneLymphoma, Mantle-CellFollow-Up StudiesTissue DonorsAmyloidosisPrognosisCord Blood Stem Cell TransplantationCell LineageBone MarrowThalidomideAntibodies, Monoclonal, Murine-DerivedStem Cell NicheBoronic AcidsAntineoplastic Agents, AlkylatingPyrazinesDoxorubicinCells, CulturedLymphomaLymphoma, FollicularLeukemia, Myeloid, AcuteAutograftsColony-Forming Units AssayPrednisoneNeoplasm, ResidualMyelodysplastic SyndromesFlow CytometryLymphoma, T-Cell, PeripheralPluripotent Stem CellsImmunosuppressive AgentsMesenchymal Stromal CellsCell SeparationHeart TransplantationNeural Stem CellsMultipotent Stem CellsHistocompatibility TestingLeukemiaAntineoplastic AgentsMice, Inbred C57BLIfosfamideBlood Component RemovalPodophyllotoxinLung TransplantationStem Cell FactorIdarubicinHistocompatibilityTransplantation ImmunologyInduction ChemotherapyCell ProliferationInduced Pluripotent Stem Cells